Erin Nicole Hecker, MD | |
3901 Rainbow Blvd, Ms 2028, Kansas City, KS 66160-8500 | |
(913) 588-6245 | |
(913) 588-6271 |
Full Name | Erin Nicole Hecker |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 11 Years |
Location | 3901 Rainbow Blvd, Kansas City, Kansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568808145 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 94-08140 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Kansas Hospital | Kansas city, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
UBM Medica today announced that CancerNetwork has been recognized by the Summit International Awards (SIA) with a Summit Emerging Media Award (Summit EMA) for being a leader in advertising through the use of innovative digital technologies.
A new study released today estimates that the global initiative to eradicate polio could provide net benefits of at least US$40-50 billion if transmission of wild polioviruses is interrupted within the next five years. The study provides the first rigorous evaluation of the benefits and costs of the Global Polio Eradication Initiative (GPEI)-the single largest project ever undertaken by the global health community. The study comes at a crucial time-following an outbreak in the Republic of the Congo and one in Tajikistan earlier this year-that highlight the risk of delays in finishing the job on polio.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical symptom management.
[T]he GOP may be positioning itself to become the dog that caught the car. Political and policy uncertainty is perhaps inevitable given the range of what the Court could do. But the Republicans need a more coherent strategy. ... An orderly unwinding of ObamaCare was always going to be difficult. But based on its disarray and confusion so far, the GOP may be making it harder.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
› Verified 2 days ago
Entity Name | Kansas University Physicians, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
UBM Medica today announced that CancerNetwork has been recognized by the Summit International Awards (SIA) with a Summit Emerging Media Award (Summit EMA) for being a leader in advertising through the use of innovative digital technologies.
A new study released today estimates that the global initiative to eradicate polio could provide net benefits of at least US$40-50 billion if transmission of wild polioviruses is interrupted within the next five years. The study provides the first rigorous evaluation of the benefits and costs of the Global Polio Eradication Initiative (GPEI)-the single largest project ever undertaken by the global health community. The study comes at a crucial time-following an outbreak in the Republic of the Congo and one in Tajikistan earlier this year-that highlight the risk of delays in finishing the job on polio.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical symptom management.
[T]he GOP may be positioning itself to become the dog that caught the car. Political and policy uncertainty is perhaps inevitable given the range of what the Court could do. But the Republicans need a more coherent strategy. ... An orderly unwinding of ObamaCare was always going to be difficult. But based on its disarray and confusion so far, the GOP may be making it harder.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Erin Nicole Hecker, MD 3901 Rainbow Blvd, Ms 2028, Kansas City, KS 66160-8500 Ph: (913) 588-6245 | Erin Nicole Hecker, MD 3901 Rainbow Blvd, Ms 2028, Kansas City, KS 66160-8500 Ph: (913) 588-6245 |
News Archive
UBM Medica today announced that CancerNetwork has been recognized by the Summit International Awards (SIA) with a Summit Emerging Media Award (Summit EMA) for being a leader in advertising through the use of innovative digital technologies.
A new study released today estimates that the global initiative to eradicate polio could provide net benefits of at least US$40-50 billion if transmission of wild polioviruses is interrupted within the next five years. The study provides the first rigorous evaluation of the benefits and costs of the Global Polio Eradication Initiative (GPEI)-the single largest project ever undertaken by the global health community. The study comes at a crucial time-following an outbreak in the Republic of the Congo and one in Tajikistan earlier this year-that highlight the risk of delays in finishing the job on polio.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical symptom management.
[T]he GOP may be positioning itself to become the dog that caught the car. Political and policy uncertainty is perhaps inevitable given the range of what the Court could do. But the Republicans need a more coherent strategy. ... An orderly unwinding of ObamaCare was always going to be difficult. But based on its disarray and confusion so far, the GOP may be making it harder.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
› Verified 2 days ago
Dr. Madhuri G Reddy, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Obgyn Dept, Ms 2028, Kansas City, KS 66160 Phone: 913-588-6257 Fax: 913-588-6271 | |
Dr. Marc Ronald Parrish, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 2028, Kansas City, KS 66160 Phone: 913-588-6201 Fax: 913-588-6271 | |
Megan Eileen Madrigal, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mailstop 2028, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6218 | |
Gene T. Lee, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: University Of Kansas Medical Center, 3901 Rainbow Blvd., Ms2028, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6271 | |
Dr. Annabel Mancillas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6271 | |
Dr. Charles W Gibbs, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mailstop 2028, Kansas City, KS 66160 Phone: 913-588-6201 Fax: 913-588-6271 | |
Lindsay R Nordwald, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Ku Women's Health Specialty Centers, 3901 Rainbow Blvd., Ms 2028, Kansas City, KS 66160 Phone: 913-588-6200 Fax: 913-588-6271 |